¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21
±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : ´ë¿õÁ¦¾à º£¾îȦ  
±³À°ÁÖÁ¦ : Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹°£¿Ü°ú¿¬±¸È¸  
´ã´çÀÚ : ±èÀºÈñ
¿¬¶ôó : 02-2135-2279  
À̸ÞÀÏ : office@thekalis.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:00~13:15 Indication setting for each approach for the beginner; Which approach should we use?  ÇÑ¿µ¼®(°æºÏÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 13:15~13:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:30~13:45 Each tip for glissonean pedicle approach in conventional and minimally invasive approach  ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 05-21 º£¾î Ȧ 13:45~14:00 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:00~14:15 The short-cut to shorten learning curve for liver surgery.  ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 14:15~14:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:30~15:00 Junior & Fellow ȸ¿ø ¼Ò°³  ÃÖ±âÈ«(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 15:00~16:00 Video presentation  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ05-21 º£¾î Ȧ 16:00~16:10   () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:10~16:30 Current status of liver diseases including HCC in Korea  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:30~16:45 Working definition of resectable HCC?  ¹Ú¹Î¼ö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:45~17:00 Recent updates of ablative therapies: RFA vs. MWA  À̹οì(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:00~17:15 TACE vs. Brigding TACE before Surgery  ¹Ú¿µ¸ñ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:15~17:30 Initial LT vs. Salvage LT  ÃÖ±Ô¼º(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:30~17:45 Role of adjuvant therapies after initial treatment for HCC  Á¶ÀºÁÖ(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 17:45~18:00 Case discussion  ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 18:00~18:10 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 18:10~18:25 KOTUS-Liver ÀÚ·á ¼öÁý ÇöȲ ¹× °³¼±¹æ¾È  ÀÌÇØ¿ø(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇÇб³À°ÇÐȸ AME ±âº»ÀÇÇб³À° Á¦µµ¿Í Á¤Ã¥ : 2022-05-21
´ÙÀ½±Û 2022 ûÁÖ½ÃÀÇ»çȸ Ãá°è Çмú´ëȸ : 2022-05-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 89 2024-04-29
20492 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY2 : 2024-05-11 0 96 2024-04-29
20491 ¼­¿ï Á¦50ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-05-11 0 92 2024-04-29
20490 ¼­¿ï ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ⸳ 52Áֳ⠱â³äÇмú´ëȸ : 2024-05-11 0 144 2024-04-29
20489 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¼ºÇü¿Ü°úÇб³½Ç â¸³ 50Áֳ⠱â³ä Çмú´ëȸ : 2024-05-11 0 88 2024-04-29
20488 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (2ÀÏÂ÷) : 2024-05-11 0 110 2024-04-29
20487 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-10 0 102 2024-04-29
20486 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-10 0 109 2024-04-29
20485 ¼­¿ï ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ 2024 Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-05-10 0 83 2024-04-29
20484 ¼­¿ï ´ëÇѼҾÆû¼Ò³â½Å°æ¿Ü°úÇÐȸ Á¦36Â÷ Á¤±âÇмú´ëȸ : 2024-05-10 0 108 2024-04-29
20483 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY1 : 2024-05-10 0 99 2024-04-29
20482 ¼­¿ï 2024³âµµ Á¦71Â÷ ´ëÇÑÁ÷¾÷ȯ°æÀÇÇÐȸ º½Çмú´ëȸ : 2024-05-10 0 142 2024-04-29
20481 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10 0 183 2024-04-29
20480 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-09 0 86 2024-04-29
20479 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-05-09 0 104 2024-04-29
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷